Search Orphan Drug Designations and Approvals
-
Generic Name: | small molecule normalizing the p53 function |
---|---|
Date Designated: | 06/12/2014 |
Orphan Designation: | Treatment of ovarian cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Critical Outcome Technologies, Inc. 700 Collip Circle Suite 213 London Canada The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-